{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:59:45Z","timestamp":1785517185002,"version":"3.56.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Nantong University Special Research Fund for Clinical Medicine","award":["2024JQ038"],"award-info":[{"award-number":["2024JQ038"]}]},{"name":"Nantong Municipal Health Commission","award":["QN2024036"],"award-info":[{"award-number":["QN2024036"]}]},{"name":"Nantong Municipal Health Commission","award":["QN2024038"],"award-info":[{"award-number":["QN2024038"]}]},{"name":"Nantong Municipal Health Commission","award":["QNZ2024055"],"award-info":[{"award-number":["QNZ2024055"]}]},{"name":"he Health Commission of Jiangsu Province","award":["MQ2024047"],"award-info":[{"award-number":["MQ2024047"]}]},{"name":"the Nantong Science and Technology Bureau","award":["MS2024009"],"award-info":[{"award-number":["MS2024009"]}]},{"name":"the Nantong Science and Technology Bureau","award":["JC2023108"],"award-info":[{"award-number":["JC2023108"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02223-2","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T02:15:16Z","timestamp":1782008116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["tRF-18-8R1546D2 is upregulated in hepatocellular carcinoma and associated with poor prognosis and tumor progression"],"prefix":"10.1007","volume":"26","author":[{"given":"Liu-Xia","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Qiang","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Wen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-ling","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Jia","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,21]]},"reference":[{"key":"2223_CR1","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1111\/liv.15953","volume":"44","author":"Y Qin","year":"2024","unstructured":"Qin Y, Han S, Yu Y, Qi D, Ran M, Yang M, Liu Y, Li Y, Lu L, Liu Y, et al. Lenvatinib in hepatocellular carcinoma: Resistance mechanisms and strategies for improved efficacy. Liver Int. 2024;44:1808\u201331. https:\/\/doi.org\/10.1111\/liv.15953.","journal-title":"Liver Int"},{"key":"2223_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","volume":"42","author":"Y Wang","year":"2023","unstructured":"Wang Y, Deng B. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev. 2023;42:629\u201352. https:\/\/doi.org\/10.1007\/s10555-023-10084-4.","journal-title":"Cancer Metastasis Rev"},{"key":"2223_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s43018-022-00357-2","volume":"3","author":"JM Llovet","year":"2022","unstructured":"Llovet JM, Pinyol R, Kelley RK, El-Khoueiry A, Reeves HL, Wang XW, Gores GJ, Villanueva A. Molecular pathogenesis and systemic therapies for hepatocellular carcinoma. Nat Cancer. 2022;3:386\u2013401. https:\/\/doi.org\/10.1038\/s43018-022-00357-2.","journal-title":"Nat Cancer"},{"key":"2223_CR4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41423-020-00572-w","volume":"18","author":"B Ruf","year":"2021","unstructured":"Ruf B, Heinrich B, Greten TF. Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells. Cell Mol Immunol. 2021;18:112\u201327. https:\/\/doi.org\/10.1038\/s41423-020-00572-w.","journal-title":"Cell Mol Immunol"},{"key":"2223_CR5","doi-asserted-by":"publisher","first-page":"101483","DOI":"10.1016\/j.gendis.2024.101483","volume":"12","author":"W Wu","year":"2025","unstructured":"Wu W, Wang X, Ma R, Huang S, Li H, Lyu X. Deciphering the roles of neddylation modification in hepatocellular carcinoma: Molecular mechanisms and targeted therapeutics. Genes Dis. 2025;12:101483. https:\/\/doi.org\/10.1016\/j.gendis.2024.101483.","journal-title":"Genes Dis"},{"key":"2223_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12943-024-02030-x","volume":"23","author":"XY Zhang","year":"2024","unstructured":"Zhang XY, Li SS, Gu YR, Xiao LX, Ma XY, Chen XR, Wang JL, Liao CH, Lin BL, Huang YH, et al. CircPIAS1 promotes hepatocellular carcinoma progression by inhibiting ferroptosis via the miR-455-3p\/NUPR1\/FTH1 axis. Mol Cancer. 2024;23:113. https:\/\/doi.org\/10.1186\/s12943-024-02030-x.","journal-title":"Mol Cancer"},{"key":"2223_CR7","doi-asserted-by":"publisher","first-page":"e0263298","DOI":"10.1371\/journal.pone.0263298","volume":"17","author":"N Ratnasari","year":"2022","unstructured":"Ratnasari N, Lestari P, Renovaldi D, Raditya Ningsih J, Qoriansas N, Wardana T, Hakim S, Signa Aini Gumilas N, Indrarti F, Triwikatmani C, et al. Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients. PLoS ONE. 2022;17:e0263298. https:\/\/doi.org\/10.1371\/journal.pone.0263298.","journal-title":"PLoS ONE"},{"key":"2223_CR8","doi-asserted-by":"publisher","first-page":"114729","DOI":"10.1016\/j.yexcr.2025.114729","volume":"453","author":"L Pan","year":"2025","unstructured":"Pan L, Zhou R, Wen Z, Lin Y, Cai H, Lin C, Xu X, Ruan L, Zeng Y, Zhang H, et al. tsRNA-10105-enriched migrasomes mediate hepatocellular carcinoma immunosuppressive microenvironment by inducing M2 Macrophage polarization. Exp Cell Res. 2025;453:114729. https:\/\/doi.org\/10.1016\/j.yexcr.2025.114729.","journal-title":"Exp Cell Res"},{"key":"2223_CR9","doi-asserted-by":"publisher","first-page":"2528978","DOI":"10.1080\/07853890.2025.2528978","volume":"57","author":"J Xu","year":"2025","unstructured":"Xu J, Chen B, Qi J, Wu J, Feng W, Jin K, Bao H, Chen L, Wang F. Evaluation of serum hsa_tsr014055 as a potential biomarker for diagnosis and prognosis of hepatocellular carcinoma. Ann Med. 2025;57:2528978. https:\/\/doi.org\/10.1080\/07853890.2025.2528978.","journal-title":"Ann Med"},{"key":"2223_CR10","doi-asserted-by":"publisher","first-page":"101608","DOI":"10.1016\/j.gendis.2025.101608","volume":"12","author":"Q Wang","year":"2025","unstructured":"Wang Q, Pan Z, Liang S, Shi Y, Dong G, Xu L, Mao Q, Jiang F. Transfer RNA-derived small RNAs (tsRNAs): A rising star in liquid biopsy. Genes Dis. 2025;12:101608. https:\/\/doi.org\/10.1016\/j.gendis.2025.101608.","journal-title":"Genes Dis"},{"key":"2223_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12943-021-01389-5","volume":"20","author":"F Jin","year":"2021","unstructured":"Jin F, Yang L, Wang W, Yuan N, Zhan S, Yang P, Chen X, Ma T, Wang Y. A novel class of tsRNA signatures as biomarkers for diagnosis and prognosis of pancreatic cancer. Mol Cancer. 2021;20:95. https:\/\/doi.org\/10.1186\/s12943-021-01389-5.","journal-title":"Mol Cancer"},{"key":"2223_CR12","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/cbdd.12994","volume":"90","author":"Y Shao","year":"2017","unstructured":"Shao Y, Sun Q, Liu X, Wang P, Wu R, Ma Z. tRF-Leu-CAG promotes cell proliferation and cell cycle in non-small cell lung cancer. Chem Biol Drug Des. 2017;90:730\u20138. https:\/\/doi.org\/10.1111\/cbdd.12994.","journal-title":"Chem Biol Drug Des"},{"key":"2223_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12943-024-01992-2","volume":"23","author":"M Zhou","year":"2024","unstructured":"Zhou M, He X, Zhang J, Mei C, Zhong B, Ou C. tRNA-derived small RNAs in human cancers: roles, mechanisms, and clinical application. Mol Cancer. 2024;23:76. https:\/\/doi.org\/10.1186\/s12943-024-01992-2.","journal-title":"Mol Cancer"},{"key":"2223_CR14","doi-asserted-by":"publisher","first-page":"41610","DOI":"10.1021\/acsami.5c05698","volume":"17","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, Chen B, Liu J, Feng W, Ren Z, Jin K, Li Y, Ju L, Chen L, Zhu G, et al. tRNA-Derived Small RNA Accelerates Tumorigenesis through Crosstalk with Tumor-Associated Macrophages, and Downregulation with Cell Membrane-Modified Polymer Nanoparticles Enables Treatment Response. ACS Appl Mater Interfaces. 2025;17:41610\u201325. https:\/\/doi.org\/10.1021\/acsami.5c05698.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2223_CR15","doi-asserted-by":"publisher","first-page":"954431","DOI":"10.3389\/fcell.2022.954431","volume":"10","author":"X Chu","year":"2022","unstructured":"Chu X, He C, Sang B, Yang C, Yin C, Ji M, Qian A, Tian Y. Transfer RNAs-derived small RNAs and their application potential in multiple diseases. Front Cell Dev Biol. 2022;10:954431. https:\/\/doi.org\/10.3389\/fcell.2022.954431.","journal-title":"Front Cell Dev Biol"},{"key":"2223_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s11658-025-00738-2","volume":"30","author":"J Lu","year":"2025","unstructured":"Lu J, Sun Y, Zhang X, Xu B, Zhu P, Zeng L, Wang X, Zhu W, Zhou P. The novel tRNA-derived fragment, tiRNA-Met, inhibits the malignant progression of triple-negative breast cancer by regulating RANBP3L via a targeted interaction with SNRPA. Cell Mol Biol Lett. 2025;30:62. https:\/\/doi.org\/10.1186\/s11658-025-00738-2.","journal-title":"Cell Mol Biol Lett"},{"key":"2223_CR17","doi-asserted-by":"publisher","first-page":"e70560","DOI":"10.1111\/jcmm.70560","volume":"29","author":"T Xu","year":"2025","unstructured":"Xu T, Hua H, Song F, Zhang N, Gao C, Chen Z. tRF-34-P4R8YP9LON4VHM Promotes Hepatocellular Carcinoma Progression and Tumour Cell-Induced Angiogenesis via the MEK\/ERK Pathway. J Cell Mol Med. 2025;29:e70560. https:\/\/doi.org\/10.1111\/jcmm.70560.","journal-title":"J Cell Mol Med"},{"key":"2223_CR18","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s11684-022-0966-6","volume":"17","author":"C Wu","year":"2023","unstructured":"Wu C, Liu D, Zhang L, Wang J, Ding Y, Sun Z, Wang W. 5\u2019-tiRNA-Gln inhibits hepatocellular carcinoma progression by repressing translation through the interaction with eukaryotic initiation factor 4A-I. Front Med. 2023;17:476\u201392. https:\/\/doi.org\/10.1007\/s11684-022-0966-6.","journal-title":"Front Med"},{"key":"2223_CR19","doi-asserted-by":"publisher","first-page":"6314","DOI":"10.1038\/s41467-021-26718-6","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wang J, Li X, Xiong X, Wang J, Zhou Z, Zhu X, Gu Y, Dominissini D, He L, et al. N(1)-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism. Nat Commun. 2021;12:6314. https:\/\/doi.org\/10.1038\/s41467-021-26718-6.","journal-title":"Nat Commun"},{"key":"2223_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/hep.32779","volume":"78","author":"YT Lee","year":"2023","unstructured":"Lee YT, Fujiwara N, Yang JD, Hoshida Y. Risk stratification and early detection biomarkers for precision HCC screening. Hepatology. 2023;78:319\u201362. https:\/\/doi.org\/10.1002\/hep.32779.","journal-title":"Hepatology"},{"key":"2223_CR21","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/cas.70003","volume":"116","author":"X Xu","year":"2025","unstructured":"Xu X, Chen J, Bai M, Liu T, Zhan S, Li J, Ma Y, Zhang Y, Wu L, Zhao Z, et al. Plasma tsRNA Signatures Serve as a Novel Biomarker for Bladder Cancer. Cancer Sci. 2025;116:1255\u201367. https:\/\/doi.org\/10.1111\/cas.70003.","journal-title":"Cancer Sci"},{"key":"2223_CR22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12964-025-02086-2","volume":"23","author":"H Cui","year":"2025","unstructured":"Cui H, Liu Z, Peng L, Liu L, Xie X, Zhang Y, Gao Z, Zhang C, Yu X, Hu Y, et al. A novel 5\u2019tRNA-derived fragment tRF-Tyr inhibits tumor progression by targeting hnRNPD in gastric cancer. Cell Commun Signal. 2025;23:88. https:\/\/doi.org\/10.1186\/s12964-025-02086-2.","journal-title":"Cell Commun Signal"},{"key":"2223_CR23","doi-asserted-by":"publisher","first-page":"e23742","DOI":"10.1002\/jcla.23742","volume":"35","author":"J Li","year":"2021","unstructured":"Li J, Jin L, Gao Y, Gao P, Ma L, Zhu B, Yin X, Sui S, Chen S, Jiang Z, et al. Low expression of tRF-Pro-CGG predicts poor prognosis in pancreatic ductal adenocarcinoma. J Clin Lab Anal. 2021;35:e23742. https:\/\/doi.org\/10.1002\/jcla.23742.","journal-title":"J Clin Lab Anal"},{"key":"2223_CR24","doi-asserted-by":"publisher","first-page":"117726","DOI":"10.1016\/j.bcp.2026.117726","volume":"246","author":"X Li","year":"2026","unstructured":"Li X, Pan Y, Zhou L, Qi L, Lu J. tRF-Gly-CCC-012 enhances malignant process in pancreatic cancer via the HNRNPC\/PHGDH axis. Biochem Pharmacol. 2026;246:117726. https:\/\/doi.org\/10.1016\/j.bcp.2026.117726.","journal-title":"Biochem Pharmacol"},{"key":"2223_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-026-00916-w","author":"X Li","year":"2026","unstructured":"Li X, Cui W, Wang Z, Chen D, Kuang Z, Jiang J, Lai Y, Zhang X, Duan C, Zhang C, et al. A tRNA-derived fragment tRF3019a promotes LUAD metastasis by stabilizing hnRNPK and enhancing MYH11 expression. Cell Mol Biol Lett. 2026. https:\/\/doi.org\/10.1186\/s11658-026-00916-w.","journal-title":"Cell Mol Biol Lett"},{"key":"2223_CR26","doi-asserted-by":"publisher","first-page":"111813","DOI":"10.1016\/j.cellsig.2025.111813","volume":"132","author":"X Yuan","year":"2025","unstructured":"Yuan X, Li W, Li J, Zhang W, Xiong Y, Tang H, Lan B, Huang J, Chen Y, Liu W, et al. tRF-3019A\/STAU1\/BECN1 axis promotes autophagy and malignant progression of colon cancer. Cell Signal. 2025;132:111813. https:\/\/doi.org\/10.1016\/j.cellsig.2025.111813.","journal-title":"Cell Signal"},{"key":"2223_CR27","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41419-020-2381-8","volume":"11","author":"K Jiang","year":"2020","unstructured":"Jiang K, Yao G, Hu L, Yan Y, Liu J, Shi J, Chang Y, Zhang Y, Liang D, Shen D, et al. MOB2 suppresses GBM cell migration and invasion via regulation of FAK\/Akt and cAMP\/PKA signaling. Cell Death Dis. 2020;11:230. https:\/\/doi.org\/10.1038\/s41419-020-2381-8.","journal-title":"Cell Death Dis"},{"key":"2223_CR28","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.semcancer.2019.09.004","volume":"62","author":"V Mohan","year":"2020","unstructured":"Mohan V, Das A, Sagi I. Emerging roles of ECM remodeling processes in cancer. Semin Cancer Biol. 2020;62:192\u2013200. https:\/\/doi.org\/10.1016\/j.semcancer.2019.09.004.","journal-title":"Semin Cancer Biol"},{"key":"2223_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.brainresbull.2021.07.013","volume":"175","author":"LC Wang","year":"2021","unstructured":"Wang LC, Cui WY, Zhang Z, Tan ZL, Lv QL, Chen SH, Shen XL. Expression, methylation and prognostic feature of EMILIN2 in Low-Grade-Glioma. Brain Res Bull. 2021;175:26\u201336. https:\/\/doi.org\/10.1016\/j.brainresbull.2021.07.013.","journal-title":"Brain Res Bull"},{"key":"2223_CR30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12935-021-02087-4","volume":"21","author":"Z Jiang","year":"2021","unstructured":"Jiang Z, Yin W, Zhu H, Tan J, Guo Y, Xin Z, Zhou Q, Cao Y, Wu Z, Kuang Y, et al. METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis. Cancer Cell Int. 2021;21:383. https:\/\/doi.org\/10.1186\/s12935-021-02087-4.","journal-title":"Cancer Cell Int"},{"key":"2223_CR31","doi-asserted-by":"publisher","first-page":"106409","DOI":"10.1016\/j.biocel.2023.106409","volume":"158","author":"X Cheng","year":"2023","unstructured":"Cheng X, Liu Z, Liang W, Zhu Q, Wang C, Wang H, Zhang J, Li P, Gao Y. ECM2, a prognostic biomarker for lower grade glioma, serves as a potential novel target for immunotherapy. Int J Biochem Cell Biol. 2023;158:106409. https:\/\/doi.org\/10.1016\/j.biocel.2023.106409.","journal-title":"Int J Biochem Cell Biol"},{"key":"2223_CR32","doi-asserted-by":"publisher","unstructured":"Li J, Wang S, He Q, Lin F, Tao C, Ding Y, Wang J, Zhao J, Wang W. High ECM2 Expression Predicts Poor Clinical Outcome and Promotes the Proliferation, Migration, and Invasiveness of Glioma. Brain Sci. 2023;13. https:\/\/doi.org\/10.3390\/brainsci13060851.","DOI":"10.3390\/brainsci13060851"},{"key":"2223_CR33","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.joca.2020.04.014","volume":"28","author":"JA Green","year":"2020","unstructured":"Green JA, Ansari MY, Ball HC, Haqqi TM. tRNA-derived fragments (tRFs) regulate post-transcriptional gene expression via AGO-dependent mechanism in IL-1beta stimulated chondrocytes. Osteoarthritis Cartilage. 2020;28:1102\u201310. https:\/\/doi.org\/10.1016\/j.joca.2020.04.014.","journal-title":"Osteoarthritis Cartilage"},{"key":"2223_CR34","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s00109-025-02566-5","volume":"103","author":"J Dai","year":"2025","unstructured":"Dai J, Ji H, Bai H, Zhong Q, Sun H, Chen M, Chen Q, Yan M, Zhang D, Zhang S. A novel tsRNA, tRF-33-6978WPRLXN4V0O inhibits breast cancer development via regulating PTEN\/AKT pathway in BHLHA15-mediated manner. J Mol Med (Berl). 2025;103:1135\u201348. https:\/\/doi.org\/10.1007\/s00109-025-02566-5.","journal-title":"J Mol Med (Berl)"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02223-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02223-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02223-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:07:43Z","timestamp":1785514063000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02223-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2223"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02223-2","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,21]]},"assertion":[{"value":"8 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: due to the missing equal contribution in the article.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted according to the guidelines of the Declaration of Helsinki and approved by the institutional Ethics Committee of the Affiliated Nantong Hospital 3 of Nantong University (approval number: EK2022023).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consents were obtained from the participants.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"270"}}